NLS Pharmaceutics AG (NLSP) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    NLS Pharmaceutics AG

    NASDAQ: NLSP · Real-Time Price · USD
    2.00
    -0.12 (-5.66%)
    At close: Oct 03, 2025, 3:59 PM
    1.98
    -0.75%
    After-hours: Oct 03, 2025, 07:41 PM EDT

    NLS Pharmaceutics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -0.8 -73.77 -61.57 -54.82
    PEG Ratio
    		 -0.00 1.19 -16.62 -1.47
    PS Ratio
    		 n/a n/a n/a n/a
    PB Ratio
    		 1.13 -101.65 309.56 1.21K
    P/FCF Ratio
    		 -0.37 -92.72 -73.18 -43.73
    P/OCF Ratio
    		 -0.37 -92.72 -73.18 -43.84
    OCF/S Ratio
    		 n/a n/a n/a n/a
    Debt / Equity Ratio
    		 n/a -0.18 n/a n/a
    Quick Ratio
    		 2.69 0.23 2.76 2.40
    Current Ratio
    		 2.69 0.23 2.75 2.38
    Asset Turnover
    		 n/a n/a n/a n/a
    Interest Coverage
    		 -29.2 -81.34 -153.49 -174.08
    Return on Equity
    		 -1.41 1.38 -5.03 -22.02
    Return on Assets
    		 -0.89 -6.59 -1.78 -2.07
    Return on Invested Capital
    		 -3.11 2.66 -2.62 -3.53
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 n/a n/a n/a n/a
    Net Profit Margin
    		 n/a n/a n/a n/a
    Pretax Profit Margin
    		 n/a n/a n/a n/a
    Operating Profit Margin
    		 n/a n/a n/a n/a
    FCF Margin
    		 n/a n/a n/a n/a
    EBITDA Margin
    		 n/a n/a n/a n/a

    Add to Watchlist